Diabetes India
- All
- News
- Videos
- Web Stories
-
Children Don't Always Look' Obese: Here's What You Might Miss
Childhood obesity isn't always visible hidden risks demand early detection and healthy habits.
-
World Obesity Day 2026: India's Child Obesity Numbers Soar, Ranks 2nd Worldwide
India ranks second globally for children living with overweight and obesity, warns the World Obesity Atlas 2026. With 41 million affected and sharp rises projected by 2040, experts urge urgent policy action, including sugar taxes and marketing curbs.
-
World Birth Defects Day: Why India Bears A High Burden Of Congenital Anomalies
On World Birth Defects Day, India's congenital anomalies burden is spotlighted with roughly 472,000 affected births annually, contributing to high neonatal mortality and disability.
-
Home Tests Beat HbA1c For Accurate Blood Sugar Control, Doctor Explains How
If you've been managing diabetes based solely on your HbA1c report every three months, you might be flying blind between appointments, and making decisions based on incomplete information.
-
Abbott, Novo Nordisk India Partner Up To Launch Second Brand Of Ozempic, Widen Access To Diabetes Drug
Abbott has entered into a commercialisation agreement with Novo Nordisk India to market a second brand of semaglutide, Extensior, in India
-
Ayush Becomes Backbone Of Preventive Healthcare, Rural Prosperity, Says Ayush Minister
Ayush is not only a system of medicine but also a movement for social transformation, rural empowerment and global leadership in holistic healthcare, Ayush Minister Prataprao Jadhav said on Friday.
-
Ozempic Revolution In India? Semaglutide Patent Expiry Sparks Generic Rush: Report
As the patent for semaglutide, the active ingredient in Ozempic, nears expiry, Indian pharmaceutical companies are preparing to launch cheaper generic versions.
-
1 In 7 Stroke Patients In India Are Under 45: Alarming National Registry Data
A new National Stroke Registry analysis reveals nearly 14 % of stroke patients in India are under 45, a demographic once considered low risk.
-
Childhood Body Weight Predicts Future Diabetes And Heart Disease Risk: New Study
A new study in Nature Communications shows that body weight at age ten and growth patterns through adolescence are strongly linked to future risks of diabetes, high cholesterol, and heart disease.
-
India Accounts For 20% Of Global Heart Attack Deaths, Says New Indian Report
The report shows India's rising heart crisis, highlights gaps in prevention, early diagnosis, and long-term cardiac care.
-
Children Don't Always Look' Obese: Here's What You Might Miss
Childhood obesity isn't always visible hidden risks demand early detection and healthy habits.
-
World Obesity Day 2026: India's Child Obesity Numbers Soar, Ranks 2nd Worldwide
India ranks second globally for children living with overweight and obesity, warns the World Obesity Atlas 2026. With 41 million affected and sharp rises projected by 2040, experts urge urgent policy action, including sugar taxes and marketing curbs.
-
World Birth Defects Day: Why India Bears A High Burden Of Congenital Anomalies
On World Birth Defects Day, India's congenital anomalies burden is spotlighted with roughly 472,000 affected births annually, contributing to high neonatal mortality and disability.
-
Home Tests Beat HbA1c For Accurate Blood Sugar Control, Doctor Explains How
If you've been managing diabetes based solely on your HbA1c report every three months, you might be flying blind between appointments, and making decisions based on incomplete information.
-
Abbott, Novo Nordisk India Partner Up To Launch Second Brand Of Ozempic, Widen Access To Diabetes Drug
Abbott has entered into a commercialisation agreement with Novo Nordisk India to market a second brand of semaglutide, Extensior, in India
-
Ayush Becomes Backbone Of Preventive Healthcare, Rural Prosperity, Says Ayush Minister
Ayush is not only a system of medicine but also a movement for social transformation, rural empowerment and global leadership in holistic healthcare, Ayush Minister Prataprao Jadhav said on Friday.
-
Ozempic Revolution In India? Semaglutide Patent Expiry Sparks Generic Rush: Report
As the patent for semaglutide, the active ingredient in Ozempic, nears expiry, Indian pharmaceutical companies are preparing to launch cheaper generic versions.
-
1 In 7 Stroke Patients In India Are Under 45: Alarming National Registry Data
A new National Stroke Registry analysis reveals nearly 14 % of stroke patients in India are under 45, a demographic once considered low risk.
-
Childhood Body Weight Predicts Future Diabetes And Heart Disease Risk: New Study
A new study in Nature Communications shows that body weight at age ten and growth patterns through adolescence are strongly linked to future risks of diabetes, high cholesterol, and heart disease.
-
India Accounts For 20% Of Global Heart Attack Deaths, Says New Indian Report
The report shows India's rising heart crisis, highlights gaps in prevention, early diagnosis, and long-term cardiac care.
